News for Biogen Inc. (BIIB)

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of ki

Biogen Inc. (NASDAQ:BIIB) Leerink Global Healthcare Conference 2025 March 10, 2025 11:20 AM ETCompany ParticipantsAlisha Alaimo - President of North...

U.S. stocks are down sharply in negative territory Monday afternoon, with those from technology sector suffering more pronounced losses, amid rising concerns about the outlook for economic growth and corporate earnings.

Shares of Biogen Inc (BIIB) surged 3.42% in mid-day trading on Mar 10. The stock reached an intraday high of $157.09, before settling at $155.53, up from it

Shares of Biogen Inc (BIIB) surged 3.32% in mid-day trading on Mar 7. The stock reached an intraday high of $154.24, before settling at $152.27, up from its

[url="]Alnylam Pharmaceuticals, Inc.[/url] (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the retirement of Dr. Phillip A. Sharp, Ph.D.

High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attenti...

Biogen Inc. (NASDAQ:BIIB) TD Cowen 45th Annual Health Care Conference March 3, 2025 9:10 AM ETCompany ParticipantsChris Viehbacher - CEOConference Call...

**media[555312,555313]**

PR NewswireSTOCKHOLM, Sweden, March 3, 2025 STOCKHOLM, Sweden, March 3, 2025 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ: BIOA B) (STOCKHOLM: BIOA B) par

Biogen Inc (BIIB) and Eisai Co., Ltd. announced on February 28, 2025, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines A

PR NewswireTOKYO and CAMBRIDGE, Mass., Feb. 28, 2025 TOKYO and CAMBRIDGE, Mass., Feb. 28, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: H

**media[552840]**

**media[552070]**

PR NewswireRICHMOND, Va., Feb. 27, 2025 RICHMOND, Va., Feb. 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) has appointed Joe Ciaffoni, currently

While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Biogen Inc.

Deep-pocketed investors have adopted a bullish approach towards Biogen BIIB, and it's something market players shouldn't ignore. Our tracking of public options ...

Biogen & Stoke team up to advance zorevunersen for Dravet syndrome globally